ALPHA (KLSE:0303) — Market Cap & Net Worth
Market Cap & Net Worth: ALPHA (0303)
ALPHA (KLSE:0303) has a market capitalization of $311.01 Million (RM1.24 Billion) as of May 27, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #14878 globally and #168 in its home market, demonstrating a 2.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ALPHA's stock price RM0.26 by its total outstanding shares 4857855500 (4.86 Billion). Analyse ALPHA (0303) cash conversion ratio to see how efficiently the company converts income to cash.
ALPHA Market Cap History: 2024 to 2026
ALPHA's market capitalization history from 2024 to 2026. Data shows change from $414.68 Million to $311.01 Million (-9.31% CAGR).
ALPHA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ALPHA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.03x
ALPHA's market cap is 2.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.26x
ALPHA's market cap is 6.26 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $414.68 Million | $167.59 Million | $52.93 Million | 2.47x | 7.83x |
| 2025 | $359.80 Million | $176.84 Million | $57.45 Million | 2.03x | 6.26x |
Competitor Companies of 0303 by Market Capitalization
Companies near ALPHA in the global market cap rankings as of May 27, 2026.
Key companies related to ALPHA by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #298 globally with a market cap of $87.05 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #992 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1057 globally with a market cap of $24.88 Billion USD ( €21.28 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1289 globally with a market cap of $19.92 Billion USD ( RM79.35 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #298 | HCA Holdings Inc | NYSE:HCA | $87.05 Billion | $392.42 |
| #992 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1057 | Fresenius SE & Co. KGaA | XETRA:FRE | $24.88 Billion | €37.79 |
| #1289 | IHH Healthcare Bhd | KLSE:5225 | $19.92 Billion | RM8.98 |
ALPHA Historical Marketcap From 2024 to 2026
Between 2024 and today, ALPHA's market cap moved from $414.68 Million to $ 311.01 Million, with a yearly change of -9.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM311.01 Million | -13.56% |
| 2025 | RM359.80 Million | -13.24% |
| 2024 | RM414.68 Million | -- |
End of Day Market Cap According to Different Sources
On May 27th, 2026 the market cap of ALPHA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $311.01 Million USD |
| MoneyControl | $311.01 Million USD |
| MarketWatch | $311.01 Million USD |
| marketcap.company | $311.01 Million USD |
| Reuters | $311.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ALPHA
Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia, Singapore, Indonesia, China, Middle East, the Philippines, and internationally. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization tre… Read more